0001209191-20-065064.txt : 20201223
0001209191-20-065064.hdr.sgml : 20201223
20201223175501
ACCESSION NUMBER: 0001209191-20-065064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201223
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baker Giles
CENTRAL INDEX KEY: 0001731843
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 201413820
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-23
0
0001308547
Dolby Laboratories, Inc.
DLB
0001731843
Baker Giles
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
0
1
0
0
SVP, Consumer Entertainment
Class A Common Stock
2020-12-23
4
M
0
21850
45.50
A
54226
D
Class A Common Stock
2020-12-23
4
S
0
21850
94.00
D
32376
D
Employee Stock Option (right to buy)
45.50
2020-12-23
4
M
0
21850
0.00
D
2023-12-15
Class A Common Stock
21850
0
D
Shares held following the reported transactions include 32,376 restricted stock units, which are subject to forfeiture until they vest.
The shares were sold in multiple transactions at prices ranging from $94.00 to $94.04, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 21,850 shares.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
/s/ Daniel Rodriguez, Attorney-in-Fact for Giles Baker
2020-12-23